Protein ISGylation: a posttranslational modification with implications for malignant neoplasms.

Explor Target Antitumor Ther

Department of Microbiology and Immunology, Faculty of Veterinary Medicine and Zootechnics, National Autonomous University of Mexico (UNAM), CDMX 04510, Mexico.

Published: August 2023

Interferon (IFN)-stimulated gene 15 (ISG15) is a member of the ubiquitin-like (UBL) protein family that can modify specific proteins via a catalytic process called ISGylation. This posttranslational modification can modulate the stability of the ISGylated proteins and protein-protein interactions. Some proteins modified by ISG15 have been identified in malignant neoplasms, suggesting the functional relevance of ISGylation in cancer. This review discusses the ISGylated proteins reported in malignant neoplasms that suggest the potential of ISG15 as a biomarker and therapeutic target in cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497404PMC
http://dx.doi.org/10.37349/etat.2023.00162DOI Listing

Publication Analysis

Top Keywords

malignant neoplasms
12
isgylation posttranslational
8
posttranslational modification
8
isgylated proteins
8
protein isgylation
4
modification implications
4
implications malignant
4
neoplasms interferon
4
interferon ifn-stimulated
4
ifn-stimulated gene
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!